These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 34154906)

  • 21. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes.
    Ko JJ; Lu J; Rascati K; Stock EM; Juan J; Suh K; Kim Y; Tabor PA; Godley PJ
    J Manag Care Spec Pharm; 2016 Jan; 22(1):32-7. PubMed ID: 27015049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
    Pepper GM; Steinsapir J; Reynolds K
    Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial.
    Martens T; Beck RW; Bailey R; Ruedy KJ; Calhoun P; Peters AL; Pop-Busui R; Philis-Tsimikas A; Bao S; Umpierrez G; Davis G; Kruger D; Bhargava A; Young L; McGill JB; Aleppo G; Nguyen QT; Orozco I; Biggs W; Lucas KJ; Polonsky WH; Buse JB; Price D; Bergenstal RM;
    JAMA; 2021 Jun; 325(22):2262-2272. PubMed ID: 34077499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expert Roundtable on Continuous Glucose Monitoring.
    Rosenfeld C; Blevins T; Aleppo G; Forlenza G; Isaacs D; Morales J; Seley J; Unger J
    Endocr Pract; 2022 Jun; 28(6):622-627. PubMed ID: 35364329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 29. Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C).
    Martens TW; Bergenstal RM; Pearson T; Carlson AL; Scheiner G; Carlos C; Liao B; Syring K; Pollom RD
    Postgrad Med; 2021 Apr; 133(3):253-264. PubMed ID: 33315495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the Impact of a Pharmacist-Led Telehealth Clinic on Diabetes-Related Goals of Therapy in a Veteran Population.
    Maxwell LG; McFarland MS; Baker JW; Cassidy RF
    Pharmacotherapy; 2016 Mar; 36(3):348-56. PubMed ID: 26877253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system.
    Yamada M; Okada S; Oda H; Nakajima Y; C Bastie C; Kasai Y; Osaki A; Shimoda Y; Shibusawa R; Uehara R; Saito T; Ozawa A; Yamada E
    Endocr J; 2020 May; 67(5):531-536. PubMed ID: 32023560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leveraging advances in diabetes technologies in primary care: a narrative review.
    Bode B; King A; Russell-Jones D; Billings LK
    Ann Med; 2021 Dec; 53(1):805-816. PubMed ID: 34184589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice.
    Furler J; O'Neal DN; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Browne JL; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins AJ; Liew D; Clarke P; Best J
    BMJ Open; 2018 Jul; 8(7):e021435. PubMed ID: 30018097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.
    Korcegez EI; Sancar M; Demirkan K
    J Manag Care Spec Pharm; 2017 May; 23(5):573-582. PubMed ID: 28448779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic improvement with a novel interim intervention technique using retrospective professional continuous glucose monitoring (GLITTER study): A study from Mumbai, India.
    Jain AB
    Diabetes Metab Syndr; 2021; 15(3):703-709. PubMed ID: 33813245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: Results of a clinical pilot program.
    Fantasia KL; Stockman MC; Ju Z; Ortega P; Crable EL; Drainoni ML; Walkey AJ; Bergstrom M; O'Brien K; Steenkamp D
    J Clin Transl Endocrinol; 2021 Mar; 24():100254. PubMed ID: 33898271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.
    Hirsch JD; Bounthavong M; Arjmand A; Ha DR; Cadiz CL; Zimmerman A; Ourth H; Morreale AP; Edelman SV; Morello CM
    J Manag Care Spec Pharm; 2017 Mar; 23(3):318-326. PubMed ID: 28230459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of hemoglobin A1c level in patients with type 2 diabetes after in-hospital diabetes education: A study based on continuous glucose monitoring.
    Torimoto K; Okada Y; Sugino S; Tanaka Y
    J Diabetes Investig; 2017 May; 8(3):314-320. PubMed ID: 27790855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.